International audienceFamilial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe leading to significantly higher risk for premature heart disease in those affected. As treatment beginning early in life is highly effective in preventing heart disease and cost-effective in these patients, screening for FH is crucial. It has therefore now been recognized by the European Commission Public Health Best Practice Portal as an effective strategy. Model programmes exist in Europe to identify young individuals with FH, which are based on cascade screening of first-degree relatives of affected individuals, universal screening for high cholesterol, opportunistic screening of high-risk individuals, or a combination of the above a...
Familial dyslipidemia, a frequent genetic cause of premature cardiovascular disease, is still underd...
Since heterozygous familial hypercholesterolemia (HeFH) is a disease that exposes the individual fro...
AIMS: The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (F...
International audienceFamilial hypercholesterolaemia (FH) is under-recognized and under-treated in E...
International audienceFamilial hypercholesterolaemia (FH) is under-recognized and under-treated in E...
Different screening strategies are currently recommended to identify children with (familial) hyperc...
PubMed ID: 28225290Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic ...
(1) Background: Familial hypercholesterolemia (FH), a most common genetic disorder, is underdiagnose...
Familial hypercholesterolaemia (FH) is the most common inherited metabolic disorder characterized by...
Aim. To conduct a cascade screening and to assess its effectiveness in the diagnosis of familial hyp...
Background and aims: Management of familial hypercholesterolaemia (FH) may vary across different set...
Background and aims: Management of familial hypercholesterolaemia (FH) may vary across different set...
Familial dyslipidemia, a frequent genetic cause of premature cardiovascular disease, is still underd...
Since heterozygous familial hypercholesterolemia (HeFH) is a disease that exposes the individual fro...
AIMS: The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (F...
International audienceFamilial hypercholesterolaemia (FH) is under-recognized and under-treated in E...
International audienceFamilial hypercholesterolaemia (FH) is under-recognized and under-treated in E...
Different screening strategies are currently recommended to identify children with (familial) hyperc...
PubMed ID: 28225290Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic ...
(1) Background: Familial hypercholesterolemia (FH), a most common genetic disorder, is underdiagnose...
Familial hypercholesterolaemia (FH) is the most common inherited metabolic disorder characterized by...
Aim. To conduct a cascade screening and to assess its effectiveness in the diagnosis of familial hyp...
Background and aims: Management of familial hypercholesterolaemia (FH) may vary across different set...
Background and aims: Management of familial hypercholesterolaemia (FH) may vary across different set...
Familial dyslipidemia, a frequent genetic cause of premature cardiovascular disease, is still underd...
Since heterozygous familial hypercholesterolemia (HeFH) is a disease that exposes the individual fro...
AIMS: The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (F...